CAPNS1 / Calpain small subunit 1 · IHC design guide

Design Immunohistochemistry for CAPNS1

Plan CAPNS1 paraffin-section IHC around cytoplasmic staining in glandular and hematopoietic cells (HPA tissue IHC). Start the catalog antibody at 1:50 (datasheet M04111-1), and compare a high-staining tissue with skeletal-muscle myocytes reported as undetected (HPA tissue IHC).

Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use

Immunohistochemistry protocol sheet for CAPNS1 (IHC for CAPNS1): expected localisation Predominantly cytoplasmic tissue staining (HPA tissue IHC), antibody M04111-1, validated IHC image, and IHC protocol steps — Printable **CAPNS1** IHC protocol sheet — expected localisation Predominantly cytoplasmic tissue staining (HPA tissue IHC), antibody M04111-1, controls and protocol steps. Open the full CAPNS1 IHC guide →

Navigate to: Protocols Staining pattern Controls Antibodies

CAPNS1 Immunohistochemistry Experimental Design Guide

Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before staining

	Expected localisation	Predominantly cytoplasmic tissue staining (HPA tissue IHC)
	Staining pattern	Cytoplasmic staining across several cell types (HPA tissue IHC)
	Antigen retrieval	EDTA pH 8.0 HIER, heat-mediated (datasheet M04111-1)
	Positive control ⓘ	Adrenal gland+4 more · see all
	Negative control ⓘ	Skeletal muscle

Important caveats

Reasons your staining may differ from the expected pattern.

	Fixation	Keep fixation consistent across paraffin sections (standard IHC practice; not target-specific)
	Caveat	Staining and RNA show medium consistency (HPA tissue IHC)
	Regulation	No expression regulator annotated (UniProt)
	Isoform / epitope	No annotated isoforms or propeptide; one 1–268 chain (UniProt)

Section 1

Recommended CAPNS1 IHC & IF Protocols

The catalog antibody’s IHC-P protocol (datasheet: M04111-1) is accompanied by three published CAPNS1 IHC protocols (PMC12632401; PMC13273926; PMC5378262).

Recommended immunohistochemistry (IHC-P) protocol parameters
Sample	Paraffin-embedded human stomach cancer tissue; fixative not specified (datasheet M04111-1)
Fixation	Image fixative and duration unreported (datasheet M04111-1); verify before use.
Sectioning	4–5 µm sections on charged slides (standard)
Deparaffinisation	Xylene, graded ethanol series to water (standard)
Antigen retrieval	Heat retrieval: EDTA pH 8.0 (datasheet M04111-1); 20 min, 95–100 °C (standard)
Peroxidase block	3% H2O2, 10 min, room temperature (standard)
Blocking	10% goat serum (datasheet M04111-1)
Primary antibody	Rabbit monoclonal (clone 22C74) anti-CAPNS1, 1:50 (datasheet M04111-1)
Primary incubation	Overnight at 4 °C (datasheet M04111-1)
Detection	HRP-conjugated secondary, DAB chromogen (datasheet M04111-1)
Counterstain	Hematoxylin, blue, dehydrate and mount (standard)
Expected result	CAPNS1-positive staining in glandular cells of adrenal gland (HPA tissue IHC: High). HPA tissue profile: General cytoplasmic expression. No signal in the no-primary control.

💡Decision noteStart with heat-mediated EDTA retrieval at pH 8.0 (datasheet: M04111-1); the liver protocols do not specify retrieval conditions (PMC12632401; PMC13273926).

Section 2

What Is the Expected CAPNS1 Staining Pattern?

CAPNS1 should show predominantly cytoplasmic staining across many cell types in paraffin sections (HPA: general cytoplasmic expression; low tissue specificity). Strong examples include adrenal glandular cells, bronchial respiratory epithelial cells and bone marrow hematopoietic cells (HPA: High). UniProt places CAPNS1 in the cytoplasm and at the cell membrane after calcium binding; it has no transmembrane segment (UniProt P04632: localization and topology). HPA rates its tissue IHC evidence Approved, with medium staining–RNA consistency (HPA: reliability).

What am I looking at on my slide?
Cytoplasmic chromogen is strong in adrenal glandular cells or bronchial epithelium.	This matches the reported compartment and high-staining cell types (HPA: general cytoplasmic expression; High in adrenal glandular and bronchial respiratory epithelial cells). Judge a run against its controls and tissue context; HPA's Approved rating still carries medium staining–RNA consistency (HPA: reliability).
Signal is exclusively nuclear, with little cytoplasmic staining, in an IHC section.	Recheck specificity and scoring before calling this the expected IHC pattern (HPA: general cytoplasmic expression). Nuclear signal alone does not prove an artefact: HPA separately approves nucleoplasm and cytosol localization in ICC-IF (HPA: subcellular). Compare compartments using the same application and controls.
Skeletal myocytes stain strongly while expected positive cells in the run do not.	That combination conflicts with the reference tissue pattern: myocytes were Not detected, whereas several glandular and hematopoietic populations were High (HPA: tissue IHC). Consider cross-reactivity or endogenous chromogen activity; use a no-primary control and review the tissue's staining distribution (standard IHC practice).
Chromogen spreads across tissue structures or appears outside identifiable cells.	A diffuse deposit cannot be scored as CAPNS1-positive cytoplasm without cellular localization (HPA: general cytoplasmic expression). Check the no-primary control for endogenous detection activity, then assess blocking, washes and detection exposure (standard IHC practice).
A known high-staining tissue shows no cellular signal.	Treat the run as unresolved before interpreting another section as negative. Adrenal glandular, bone marrow hematopoietic and bronchial epithelial cells are reported High (HPA: tissue IHC); check tissue preservation, retrieval and detection with appropriate run controls (standard IHC practice).

💡Expected CAPNS1 appearanceA convincing positive is identifiable cytoplasmic staining, potentially strong in HPA High cell populations, with a distribution that follows cells rather than a uniform chromogen haze; strong skeletal-myocyte staining warrants review because HPA reports myocytes as Not detected (HPA: tissue IHC).

How each factor affects the staining
Tissue and cell context	CAPNS1 has low tissue specificity, yet reported cell-level intensity varies: several glandular, epithelial, glial and hematopoietic populations are High; skeletal myocytes are Not detected (HPA: tissue IHC). Interpret the named cell population, not a whole-section average.
Compartment and application	Tissue IHC is described as generally cytoplasmic (HPA: tissue IHC). ICC-IF additionally supports nucleoplasm and cytosol (HPA: approved subcellular locations). Those ICC-IF observations do not make an exclusively nuclear paraffin-section result the expected IHC pattern.
Calcium-dependent location	CAPNS1 can translocate from cytoplasm to plasma membrane upon calcium binding (UniProt P04632: localization). A membrane-associated edge may therefore merit assessment in context; the record does not specify its frequency or intensity in paraffin IHC.
Topology and processing	The sequence has no transmembrane segment, signal peptide or propeptide; the annotated chain spans residues 1–268 (UniProt P04632: topology and processing). These annotations do not establish an IHC epitope or a retrieval condition.
Validation and fixation evidence	The listed antibody HPA006872 is Approved for IHC and ICC, while HPA describes medium staining–RNA consistency for tissue IHC (HPA: antibody validation; reliability). No target-specific fixation sensitivity or antigen-retrieval result is supplied; optimize those steps with run controls (standard IHC practice).

Why is my staining missing, weak or wrong?
Situation	Likely cause	Next action
Known high-staining tissue is blank.	A staining-run problem is possible when HPA High cells lack signal (HPA: adrenal glandular, bone marrow hematopoietic and bronchial epithelial cells). The supplied sources do not identify a CAPNS1-specific fixation failure.	Verify the positive-control tissue and detection reagents; review retrieval and antibody dilution using the validated IHC procedure available to the lab (standard IHC practice). Avoid assigning a biological negative until the control works.
Signal is faint in a selected tissue.	The chosen cells may normally stain weakly: duodenal and small-intestinal glandular cells, ovarian stroma cells and cardiomyocytes are listed Low (HPA: tissue IHC).	Compare with an HPA High cell population in a parallel section before changing conditions (HPA: tissue IHC). If that control is also weak, review retrieval, detection and dilution as general IHC variables (standard IHC practice).
Only nuclei stain in paraffin IHC.	The result diverges from HPA's general cytoplasmic tissue pattern, although nucleoplasm is an approved ICC-IF location (HPA: tissue IHC; subcellular). The different application limits a direct comparison.	Inspect the cytoplasmic positive control and no-primary control, then reassess localization and staining specificity (standard IHC practice). Report the observed compartment rather than recasting ICC-IF localization as the expected paraffin IHC result.
Strong staining appears in skeletal myocytes.	HPA reports myocytes as Not detected (HPA: skeletal muscle). Unexpected staining could reflect cross-reactivity or endogenous detection activity; appearance alone cannot distinguish them (standard IHC practice).	Run a no-primary control, inspect whether chromogen is cellular, and compare a known high-staining cell population in the same run (HPA: tissue IHC; standard IHC practice).
The whole section has diffuse color.	Broad extracellular or structure-independent color does not match the reported cellular cytoplasmic pattern (HPA: tissue IHC). Endogenous detection activity or excess background is possible (standard IHC practice).	Check the no-primary control; review blocking, washes and chromogen development, then score only interpretable cells (standard IHC practice).
Can an IF or ICC image define the IHC-positive pattern?	ICC-IF supports nucleoplasm and cytosol in imaged cells, whereas tissue IHC is described as generally cytoplasmic (HPA: subcellular; tissue IHC). They are separate application observations.	Use the ICC-IF localization as context, and judge paraffin IHC against tissue IHC observations and its own controls (HPA: tissue IHC; standard IHC practice). Consult the separate IF/ICC guide for that application.

Source: UniProt P04632 Human Protein Atlas tissue Human Protein Atlas subcellular

Experiment evidence

IHC & IF images showing CAPNS1 staining

IHC analysis of CAPNS1 using anti-CAPNS1 antibody (M04111-1). CAPNS1 was detected in a paraffin-embedded section of human stomach cancer tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1:50 rabbit anti-CAPNS1 Antibody (M04111-1) overnight at 4°C. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using HRP Conjugated Rabbit IgG Super Vision Assay Kit (Catalog # SV0002) with DAB as the chromogen.

M04111-1 · IHCIHC analysis of CAPNS1 using anti-CAPNS1 antibody (M04111-1). CAPNS1 was detected in a paraffin-embedded section of human stomach cancer tis

IHC analysis of CAPNS1 using anti-CAPNS1 antibody (M04111-1). CAPNS1 was detected in a paraffin-embedded section of rat testis tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1:50 rabbit anti-CAPNS1 Antibody (M04111-1) overnight at 4°C. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using HRP Conjugated Rabbit IgG Super Vision Assay Kit (Catalog # SV0002) with DAB as the chromogen.

M04111-1 · IHCIHC analysis of CAPNS1 using anti-CAPNS1 antibody (M04111-1). CAPNS1 was detected in a paraffin-embedded section of rat testis tissue. Heat

HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000126247-CAPNS1/tissue/cerebral+cortex#imid_2111088

HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000126247-CAPNS1/tissue/colon#imid_2111030

HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000126247-CAPNS1/tissue/liver#imid_2111015

HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000126247-CAPNS1/tissue/kidney#imid_2111024

HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA006872; green = CAPNS1, blue = nucleus, red = microtubules.

← swipe / scroll for more images →

Real IHC / IF data behind the staining-pattern expectations in this section.

Sample controls for CAPNS1 IHC & IF

🧪Run bone marrow first: hematopoietic cells should stain (HPA: High in hematopoietic cells). Use skeletal muscle myocytes as the negative tissue (HPA: Not detected in myocytes); on the positive slide, independently verified negative cells should show counterstain only, without specific DAB signal (standard IHC practice).

Positive control tissue: Adrenal gland (Glandular cells, HPA High)

Negative control tissue: Skeletal muscle (HPA Not detected)

ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show CAPNS1 in A-431, U-251MG, with annotated localisation: Nucleoplasm (approved), Cytosol (approved) (HPA subcellular).

Technical controls: Include a no-primary, secondary-only control; a concentration-matched rabbit IgG isotype control for the catalog antibody (selected-SKU caption: rabbit primary); and CAPNS1-knockout tissue as a biological negative, if available (standard IHC practice). Quench endogenous peroxidase and check for signal associated with myeloid cells in bone marrow (HPA: bone marrow hematopoietic cells; standard IHC practice).

⚠️Feasibility: A target-specific fixation window and fixation effect are unreported, and the selected-SKU paraffin-section caption does not state its fixative (selected-SKU caption: fixative not stated). The caption uses heat retrieval in EDTA at pH 8.0, but does not establish that retrieval is required; there is no supplied basis to call frozen sections or IF easier (selected-SKU caption: EDTA retrieval; HPA: ICC-IF images in A-431 and U-251MG). In bone marrow, endogenous myeloid peroxidase can complicate DAB interpretation (HPA: bone marrow hematopoietic cells; standard IHC practice).

HPA tissue IHC evidence for CAPNS1

Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Approved — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue	Cell type	Level	Evidence	Source
Adrenal gland	Glandular cells	High	Protein (IHC)	HPA →
Bone marrow	Hematopoietic cells	High	Protein (IHC)	HPA →
Breast	Glandular cells	High	Protein (IHC)	HPA →
Bronchus	Respiratory epithelial cells	High	Protein (IHC)	HPA →
Caudate	Glial cells	High	Protein (IHC)	HPA →

Undetected expression · recommended negative controls

Tissue	Cell type	Level	Evidence	Source
Skeletal muscle	Myocytes	Not detected	Protein (IHC)	HPA →

Section 3

Advanced CAPNS1 IHC Tips

Use the catalog antibody’s paraffin section IHC example as a starting point, then assess compartment, cell type and controls together.

Which retrieval conditions should I start with for CAPNS1 in paraffin sections?

Start with heat mediated retrieval in EDTA at pH 8.0 (datasheet M04111-1). The catalog antibody’s paraffin section example used that retrieval before 10% goat serum blocking and a 1:50 primary dilution overnight at 4°C (datasheet M04111-1). If staining is weak, vary heating duration in matched sections while keeping buffer and detection conditions fixed, and check whether tissue structure remains intact. Judge any gain against a concurrently processed positive control and a no primary control; stronger diffuse DAB alone does not establish improved CAPNS1 detection.

How should I troubleshoot fixation related loss of CAPNS1 staining?

The paraffin section caption does not state a fixative, so CAPNS1 sensitivity to fixation remains unknown for this antibody (datasheet M04111-1). Record the actual fixative and processing history, then compare sections processed under matched conditions rather than attributing a weak result to CAPNS1’s topology or modifications. Keep the documented EDTA retrieval at pH 8.0 and 1:50 primary dilution constant during that comparison (datasheet M04111-1). Examine tissue preservation and staining in a concurrent positive control; if both deteriorate, investigate processing and detection before drawing a biological conclusion about the test specimen.

Is membranous or nuclear staining credible for CAPNS1?

Expect a predominantly cytoplasmic IHC pattern because the tissue profile describes general cytoplasmic expression (HPA tissue IHC). CAPNS1 can move to the plasma membrane upon calcium binding, although it has no transmembrane segment (UniProt P04632). Nucleoplasm and cytosol are approved locations in cell imaging, which provides context but does not by itself validate a nuclear DAB pattern in tissue (HPA subcellular). At the documented 1:50 primary dilution (datasheet M04111-1), assess compartment boundaries across intact cells and compare any unusual membranous or nuclear pattern with controls and tissue morphology before assigning it to CAPNS1.

Could isoforms or epitope masking explain uneven CAPNS1 staining?

The supplied record lists 0 annotated isoforms and a 1–268 mature chain, so it does not support assigning different IHC patterns to named CAPNS1 isoforms (UniProt P04632). It lists EF hand regions and modifications including phosphoserine at position 6 and acetyllysine at position 179 (UniProt P04632). The antibody epitope is unspecified here; therefore, a modification dependent staining explanation cannot be confirmed from these data. Compare matched sections using the documented EDTA retrieval at pH 8.0 (datasheet M04111-1), and evaluate morphology and controls before treating uneven signal as an epitope effect.

How should I plan an IF follow up to a CAPNS1 IHC pattern?

Treat IF as a separate validation experiment: the supplied antibody example documents paraffin section chromogenic IHC, while the subcellular record reports nucleoplasm and cytosol in cell imaging (datasheet M04111-1; HPA subcellular). Multiplex CAPNS1 with an independently validated marker for the cell type implicated by the IHC result, and include single stain controls to check channel bleed through. Select a fluorophore channel with low autofluorescence in that specimen and confirm the signal with an unstained control. Because CAPNS1 lacks a transmembrane segment, test permeabilisation appropriate for intracellular epitopes while preserving cell structure; compare permeabilised and untreated preparations before interpreting membrane adjacent fluorescence (UniProt P04632).

What should I check when CAPNS1 DAB staining is diffuse?

Run a no primary control to locate signal from the detection system, and inspect unstained tissue for endogenous pigment before adjusting the antibody. Include a peroxidase blocking step as part of the general HRP and DAB workflow, particularly when endogenous enzyme activity could mimic specific staining. The reported example used 10% goat serum blocking, a 1:50 primary dilution overnight at 4°C, and an HRP based DAB readout (datasheet M04111-1). If controls are clean, titrate primary antibody and assess whether signal resolves into intact cell cytoplasm, the principal tissue IHC pattern reported for CAPNS1 (HPA tissue IHC).

How can I quantify CAPNS1 IHC across heterogeneous tissue? ⚠ ANSWER MARKED FOR VERIFICATION

Define cell classes and tissue regions before scoring, because the tissue profile shows differing levels across cell types (HPA tissue IHC). In intact regions, record the percentage of positive cells and staining intensity, then calculate an H-score from intensity categories 0–3 if that is your prespecified endpoint. For infiltrating populations, positive cell density per mm² can complement an H-score; normalise counts to viable tissue area or the total number of cells in the same annotated class. Keep retrieval at pH 8.0, staining batch, imaging settings and positivity threshold consistent across compared sections (datasheet M04111-1).

How do I distinguish true CAPNS1 staining from tissue artefact?

A credible result should fit cell morphology and the broadly cytoplasmic tissue pattern reported for CAPNS1 (HPA tissue IHC). Compare staining in the relevant cell class: high signal is reported in bone marrow hematopoietic cells, whereas skeletal muscle myocytes are listed as not detected (HPA tissue IHC). Disregard apparent enrichment limited to section edges or necrotic areas until it survives review of adjacent intact tissue and controls. Check a no primary section and the peroxidase block when DAB appears in unexpected cells or compartments; the documented assay uses HRP and DAB after pH 8.0 EDTA retrieval (datasheet M04111-1).

Boster reagents

Best CAPNS1 / Calpain small subunit 1 IHC Antibodies

Real IHC images show CAPNS1 staining in paraffin-embedded human stomach cancer and rat testis with M04111-1 (M04111-1 image captions). Both antibodies list IF/ICC, but neither provides an IF image (catalog applications/images).

Real IHC data

Anti-Calpain S1 Rabbit Monoclonal Antibody

Cat # M04111-1

View product →

M04111-1 is the sole SKU with a rendered card; its IHC images show paraffin-embedded human stomach cancer and rat testis (M04111-1 image captions). It also lists IF/ICC and human, mouse and rat reactivity, although no IF image is supplied (M04111-1 catalog applications/reactivity/images).

Which to pick: Choose M04111-1 for tissue IHC because its own captions document staining in paraffin-embedded human and rat sections; the fixative is unreported (M04111-1 image captions). For IF/ICC, M04111 is a rabbit monoclonal listed for both applications at 1:50–1:200, but has no IF image (M04111 catalog). For work across species, both rabbit monoclonals list human, mouse and rat reactivity; only M04111-1 has pictured IHC results, in human and rat tissue (catalog titles/reactivity; M04111-1 image captions).

Each figure is that product's own IHC / IF validation image from its datasheet.

References

UniProt Consortium. UniProt entry P04632 (CPNS1_HUMAN, Calpain small subunit 1).
Human Protein Atlas. CAPNS1 tissue IHC expression (reliability: Approved).
Human Protein Atlas. CAPNS1 subcellular location (ICC-IF): Localized to the nucleoplasm and cytosol..
Human Protein Atlas. CAPNS1 antibody validation summary (1 antibodies).
Calpain-4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Alcohol-Related Liver Disease. bioRxiv : the preprint server for biology 2025 — PMC12632401.
Calpain-4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Experimental Alcohol-Related Liver Disease. Alcohol, clinical & experimental research 2026 — PMC13273926.
miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver. Cancer science 2017 — PMC5378262.
Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis. Arthritis research & therapy 2022 — PMC9210712.
PubMed PMID:3016651 — UniProt-cited evidence.
PubMed PMID:3024120 — UniProt-cited evidence.
PubMed PMID:14702039 — UniProt-cited evidence.